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Abstract: BACKGROUND: Drug reaction with eosinophilia and systemic symptoms is a severe form of drug-induced
reaction with multiorgan involvement. 
OBJECTIVES: The aim of this study is to evaluate the epidemiological, clinical and pathological features and prog-
nosis of this drug reaction among patients seen at a dermatology service. 
METHOD: Retrospective review of medical records of ten patients diagnosed with drug reaction with eosinophilia
and systemic symptoms at the Federal University of São Paulo, from august 2008 to may 2011. 
RESULTS: Phenytoin was the leading cause of drug reaction with eosinophilia and systemic symptoms in our cases,
followed by allopurinol. Abnormal liver function tests were observed in 7 patients and renal function impairment
in 2 patients. In all cases, patients were hospitalized and the culprit drug was withdrawn. The main treatment
was systemic corticosteroid. Drug reaction with eosinophilia and systemic symptoms resulted in death in 2 cases.
The causes of death were septic shock and hepatic failure. 
CONCLUSION: Our mortality rate of 20%, supports that drug reaction with eosinophilia and systemic symptoms is
a severe form of drug-induced reaction and must be recognized by all dermatologists. 
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Resumo: FUNDAMENTOS: A reação a droga com eosinofilia e sintomas sistêmicos é uma reação medicamentosa
severa com envolvimento de múltiplos órgãos. 
OBJETIVO: Avaliar as características epidemiológicas, clínicas, histológicas e o prognóstico dessa reação medica-
mentosa entre os pacientes atendidos pelo serviço da dermatologia. 
MÉTODOS: Levantamento retrospectivo dos prontuários de dez pacientes diagnosticados com reação a droga com
eosinofilia e sintomas sistêmicos pelo serviço de dermatologia da Universidade Federal de São Paulo, entre agos-
to de 2008 e maio de 2011. 
RESULTADOS: A fenitoína foi a principal causa de reação a droga com eosinofilia e sintomas sistêmicos entre os
pacientes, seguida pelo alopurinol. A alteração das enzimas hepáticas foi observada em sete pacientes e diminui-
ção da função renal em dois casos. Todos os pacientes estavam hospitalizados e o medicamento implicado foi
suspenso. O principal tratamento foi corticóide sistêmico. Dois pacientes faleceram devido à síndrome reação a
droga com eosinofilia e sintomas sistêmicos. A causa da morte foi choque séptico e falência hepática. 
CONCLUSÃO: A mortalidade de 20% entre os pacientes do estudo confirma que essa reação induzida por droga é
grave e deve ser reconhecida por todos os dermatologistas. 
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INTRODUCTION
Drug-induced hypersensitivity syndrome
(DIHS) or drug reaction with eosinophilia and syste-
mic symptoms (DRESS) is a severe form of drug-indu-
ced reaction with multiorgan involvement. It is cha-
racterized by fever, rash, hepatic dysfunction, haema-
tological abnormalities and lymphadenopathy. DRESS
usually starts 2-6 weeks after the initiation of drug the-
rapy, and the possible persistence or aggravation of
symptoms can occur despite the discontinuation of
the culprit drug. 1-3
Recognizing this syndrome is of particular
importance, as the mortality rate is up to 10%. 1-3 The
syndrome may proceed to Stevens–Johnson syndrome
or toxic epidermal necrolysis. 4
It is still a matter of debate whether reactivation
of several herpes viruses in the course of the disease
is part of the syndrome. 1,3
A total of 44 drugs were described to be associa-
ted with DRESS. Of these, the most frequently repor-
ted drugs were carbamazepine, allopurinol, sulfasala-
zine, phenobarbital, lamotrigine, and nevirapine. 1
The aim of this study was to evaluate epidemiological,
clinical and pathological features and prognosis of
patients with DRESS syndrome of our University
Hospital in São Paulo (Brazil).
MATERIALS AND METHODS
All DRESS patients diagnosed at Federal
University of São Paulo, department of dermatology,
from august 2008 to may 2011 were included.
Demographic characteristics, clinical course, culprit
drugs, latency periods, extent of organ involvement,
laboratory results, pathological findings, complica-
tions and outcome data were collected.
Histopathological findings of skin biopsies were also
reviewed. 
We used the RegiSCAR’s scoring system recently
published to classify the cases. 5 The scoring system is
shown in table 1.5 Detection of HHV-6 infection was
not performed. The study was approved by the
Research Ethics Committee of the Federal University
of São Paulo.
RESULTS
There were 10 total cases (6 male and 4 fema-
le). The mean age was 45,7 years (range 20–66 years)
with a median age of 48 years. 
Phenytoin (4 of 10, 40%) was the leading cause
of DRESS in our series of cases, followed by allopuri-
nol (2 of 10, 20%), carbamazepine (1 of 10, 10%) and
diclofenac (1 case of 10, 10%). In one additional case
both carbamazepine and phenytoin were probably
implicated. One patient received multiple medica-
tions during hospitalization and his diagnosis was
made from medical history, histological examination
consistent with drug reaction and other tests negative
for bacteremia and hepatitis. 
In seven cases, information concerning the time
period from using the culprit drug to onset of DRESS
were available and ranged from 2 to 6 weeks. 
The cutaneous eruption was described as a
maculopapular rash or a generalized exanthematous
rash in all patients. One patient had also oral mucosa
involvement. 
A history of fever (> 38°C) was seen in 7
patients (70%); 2 patients had lymphadenopathy
(20%) and 4 patients had facial edema (40%). 
Abnormal liver function tests were observed in
7 patients and renal function impairment in 2
patients. No patient had involvement of the pancreas
and heart. 
Haematological abnormalities included leuko-
cytosis (> 10 000/mL) in all patients, eosinophilia (>
1500/mL) in 9 patients (90%), and atypical lymphocy-
tes in one patient (10%).
Skin biopsies were performed in nine patients.
Interface dermatitis was observed in 6 patients. Three
skin biopsy specimens showed vasculitis. The perivas-
cular inflammation was infiltrated by mixed cells in
four patient and eosinophils in two patients. We tried
to correlate histological findings with the drug invol-
ved, but it was not possible. Different drugs have
determined similar histological manifestations, as well
as reactions caused by the same drug also exhibited
distinct findings on biopsy tissue. 
According to scoring System for Classifying
DRESS six cases were classified as definitive cases and
four as probable cases.
In all cases, patients were hospitalized and the
culprit drug was withdrawn. The main treatment was
systemic corticosteroid (oral prednisone 1mg/kg/day).
DRESS syndrome resulted in death in 2 cases. The
cause of death was septic shock in patient number 2
and hepatic failure and septic shock in patient number
8. All data from the 10 patients are shown in table 2.
DISCUSSION
Male accounted for the majority of the cases in
this sample. There were 6 males and 4 females. Articles
published with a large number of patients showed 
different results regarding gender predominance.1,2,6,7
In certain populations males predominate and in
others females. The mean age was 45,7 years (ranging
from 20–66 years). Previous studies show mean age of
40,7 years and 51 years.1,2,7
In this study, phenytoin was the most common
culprit drug. Such finding differs from Taiwan studies,
but is in accordance with two previous studies from
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Europe.2,6-8 In Taiwan allopurinol was the leading
cause of DRESS and in Europe phenytoin and carba-
mazepine were mostly involved. 2,6-8 In Brazil previous-
ly reported cases of DRESS were due to anticonvulsi-
vants. 9,10
Seven cases of DRESS syndrome were reported
with clinical features appearing 2-6 weeks after adminis-
tration of the suspected drug. This corresponds to the
latency period commonly reported in the literature. 1,6,8,11
Fever was seen in 7 patient (70%) and this
result was similar to others that reported fever in 72-
87% of patients.2,7 We observed two patients with
lymphadenopathy, which is one of the criteria for diag-
nosis.5 Four patients had facial edema and this finding
is common among patients diagnosed with DRESS
syndrome. However, such symptom is not part of any
diagnostic criteria. 5 The liver was the most frequently
involved internal organ and others studies showed
similar results. 1,2,7
All patients had leukocytosis (>10 000/mL) and
9 (90%) had eosinophilia. This percentage was higher
than previously reported. 2,6,7 Two patients had atypi-
cal lymphocytes and one of them had atypical lympho-
cytes without eosinophilia. According to diagnostic
criteria eosinophilia is not a constant finding and the
acronym DRESS is questioned as eosinophilia does
not necessarily need to be present in this syndrome. 5
Histological findings were similar to those
reported in other studies that showed interface der-
matitis in most patients who underwent skin biopsy.2,7
Two patients had leukocytoclastic vasculitis and two
patients presented with infiltration of eosinophils,
such findings were also reported in a previous study
from Taiwan. 2 We could not establish a correlation bet-
ween the drug and histological features, but maybe it
might be possible with larger number of patients.
Our therapeutic approach consisted on with-
drawal of the suspected drug and administration of
systemic corticosteroids and one patient received also
antihistamine. Such approach is consistent with
published studies.1,2,3,6,7,11
During hospitalization systemic corticosteroids
was gradually tapered and hematologic and biochemi-
cal tests were performed. One patient had recurrence
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TABLE 1: Scoring System for Classifying DRESS cases as definite, probable, possible, or no case - according
Kaurdaun et al, 2007
Score
Fever ≥38.5°C
Enlarged lymph nodes
Eosinophilia
Eosinophils
Eosinophils, if leukocytes < 4.000/μL
Atypical lymphocytes
Skin involvement
Skin rash extent (% body surface area) 
Skin rash suggesting DRESS
Biopsy suggesting DRESS
Organ involvement*
Liver
Kidney
Muscle/heart
Pancreas
Other organ
Resolution ≥15 days
Evaluation of other potential causes
Antinuclear antibody
Blood culture
Serology for HAV/HBV/HCV
Chlamydia/mycoplasma
If none positive and ≥3 of above negative
-1
No/U
No
No
No/U
0
Yes
No/U
No/U
No/U
No/U
U
Yes/U
No/U
No/U
No/U
No/U
No/U
Yes
1
Yes
700-1.499/μL
10%-19.9%
yes
>50%
yes
Yes
Yes
Yes
Yes
Yes
Yes
2
≥1.500/μL
≥20%
DRESS = Drug Reaction with Eosinophilia and Systemic Symptom; U = unknown/unclassifiable; HAV = hepatitis A virus; HBV
=hepatitis B virus; HCV = hepatitis C virus.
*After exclusion of other explanations: 1, one organ; 2, two or more organs. Final score < 2, no case; final score 2-3; possible
case; final score 4-5, probable case; final score > 5, definite case.
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TABLE 2: Epidemiological, clinical and pathological data of DRESS patients
Patient
N.
1
2
3
4
5
6
7
8
9
10
Gender/
Age
(years)
M/26
M/66
F/20
M/59
F/52
F/38
F/62
M/26
M/64
M/44
Culprit 
drugs
carbamaze-
pine
diclofenac
phenytoin
Phenytoin/
carbamaze-
pine
phenytoin
allopurinol
phenytoin
phenytoin
allopurinol
>4 drugs
suspected
Latency 
period 
(weeks)
6
NA
3
NA
4
3
4
2
3
NA
Cutaneous 
eruption
generalized
maculopapular
rash
desquamative 
erythroderma
generalized
exanthematous
rash
disseminated
maculopapular
rash
disseminated
maculopapular
exanthema
maculopapular
rash on trunk
and limbs
generalized
exanthematous
rash
Generalized
exanthematous
rash, oral mucosa
involvement
Disseminated
maculopapular
exanthema
generalized
purpuric macu-
lopapular rash 
systemic
involvement
and other 
findings
Fever, liver
Liver
Fever
Fever, facial
edema
Lymphadenopa
thy, facial
edema
Fever, facial
edema, liver
Fever, facial
edema, liver
Fever, facial
edema, liver,
kidney
Lymphadenopa
thy, liver, kidney
Fever, liver
WBC (/μL) /
eosinophil %
33.700/24,1
13.000/24,9
24.300/16
16.400/28
21.000/39
65.300/28,
atypical 
lymphocytes
12.900/21
32.400/17
12.200/33
40.600/0, 
atypical 
lymphocytes
Skin rash
(biopsy)
Interface dermatitis, 
perivascular infiltra-
tes of mixed cells
Spongiotic dermati-
tis with eosinophils
and focal interface
dermatitis
dermal infiltrates of
mixed cells and  
oedema
Leukocytoclastic 
vasculitis with 
eosinophils
Leukocytoclastic 
vasculitis
Interface dermatitis,
perivascular infiltra-
tes of mixed cells
Interface dermatitis
and superficial 
vasculitis
Dense dermal 
infiltrate of mixed
inflammatory cells
and oedema
Dyskeratotic cells,
spongiosis, exocyto-
sis, vacuolar changes
of the basal cells,
mononuclear cells
at the interface and
around dermal vessels
NA
Scoring
System
for
Classifyin
g DRESS
6
5
5
6
5
6
6
8
5
6
Treatment
systemic
corticosteroid
systemic
corticosteroid
systemic
corticosteroid
systemic
corticosteroid
systemic
corticosteroid
systemic
corticosteroid
systemic
corticosteroid
systemic
corticosteroid
systemic
corticosteroid
Systemic 
corticosteroid
outcome
relapse
died
recovery
recovery
recovery
recovery
recovery
died
recovery
recovery
NA: not available.
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of the syndrome and according to others studies
relapse of the condition is often seen.1,6,8
In our study, 2 patients died, an overall mortali-
ty rate of 20%. The cause of death was septic shock in
patient number 2 and hepatic failure and septic shock
in patient number 8. In both cases the implicated
drugs were suspended early. Previous studies revealed
the same causes of death, but our mortality rate was
higher than the reported in Europe and Taiwan. 1,2,7
CONCLUSION
We studied 10 patients with DRESS, regarding
epidemiological, clinical, laboratorial and histological
aspects. The drugs mostly implicated were anticonvul-
sants. Our mortality rate was 20%, supporting that
DRESS is a severe form of drug-induced reaction and
must be recognized by all dermatologists. ❑
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